Screener
Vor Biopharma VOR Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities | 321,652 | 58,722 |
| Prepaid expenses | 6,394 | 1,152 |
| Other current assets | 2,859 | 1,745 |
| Total current assets | 500,778 | 458,105 |
| Restricted cash | 168 | 168 |
| Property and equipment, net | 565 | 533 |
| Operating lease right-of-use assets | 2,827 | 2,936 |
| Other assets | 2,408 | 2,384 |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's total current assets?
- Vor Biopharma (VOR) reported total current assets of $500.78M in Q1 2026.
- How has Vor Biopharma's total current assets changed year-over-year?
- Vor Biopharma's total current assets increased by 672.2% year-over-year, from $64.85M to $500.78M.
- What is the long-term trend for Vor Biopharma's total current assets?
- Over 5 years (2020 to 2025), Vor Biopharma's total current assets has grown at a 56.3% compound annual growth rate (CAGR), from $49.11M to $458.11M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Vor Biopharma's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude